Abstract:Inspired by our previous finding that disesquiterpenoids showed more potent antihepatoma cytotoxicity than their corresponding parent monomers, natural product‐like guaianolide‐germacranolide heterodimers were designed and synthesized from guaianolide diene and germacranolides via a biomimetic Diels–Alder reaction to provide three antihepatoma active dimers with novel scaffolds. To explore the structure–activity relationship, 31 derivatives containing ester, carbamate, ether, urea, amide, and triazole functional groups at C‐14′ were synthesized and evaluated for their cytotoxic activities against HepG2, Huh7, and SK‐Hep‐1 cell lines. Among them, 25 compounds were more potent than sorafenib against HepG2 cells, 15 compounds were stronger than sorafenib against Huh7 cells, and 17 compounds were stronger than sorafenib against SK‐Hep‐1 cells. Compound 23 showed the most potent cytotoxicity against three hepatoma cell lines with IC50 values of 4.4 μM (HepG2), 3.7 μM (Huh7), and 3.1 μM (SK‐Hep‐1), which were 2.7‐, 2.2‐, and 2.8‐fold more potent than sorafenib, respectively. The underlying mechanism study demonstrated that compound 23 could induce cell apoptosis, prevent cell migration and invasion, cause G2/M phase arrest in SK‐Hep‐1 cells. Network pharmacology analyses predicted PDGFRA was one of the potential targets of compound 23, and surface plasmon resonance (SPR) assay verified that 23 had strong affinity with PDGFRA with a dissociatin constant (KD) value of 90.2 nM. These promising findings revealed that structurally novel guaianolide‐germacranolide heterodimers might provide a new inspiration for the discovery of antihepatoma agents.

Synthesis, and discovery of a potential anti-HepG2 agents: coumarin derivatives containing 3-Aryl isoxazolyl moiety

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis and Biological Evaluations of N′-substituted Methylene-4-(quinoline-4-amino) Benzoylhydrazides As Potential Anti-Hepatoma Agents

Development of Novel 9-O-substituted-13-octylberberine Derivatives As Potential Anti-Hepatocellular Carcinoma Agents

Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs.

Design, Synthesis and Biological Evaluation of Novel 9-N-substituted-13-alkylberberine Derivatives from Chinese Medicine As Anti-Hepatocellular Carcinoma Agents.

Synthesis, Preliminary Structure-Activity Relationships and Biological Evaluation of Pyridinyl-4,5-2h-isoxazole Derivatives As Potent Antitumor Agents

Design and synthesis of guaianolide‐germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma

Synthesis and Biological Evaluation of Novel Derivatives of Gambogic Acid As Anti-Hepatocellular Carcinoma Agents

Synthesis and Biological Evaluation of Novel 2,4,5-Substituted Pyrimidine Derivatives for Anticancer Activity

Synthesis and Cytotoxic Activity of Coumarin Derivatives Containing Benzotriazole Moieties

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

Design, Synthesis and Biological Evaluation of Novel 3-Substituted 4-Anilino-coumarin Derivatives As Antitumor Agents

A Novel Class of C14-sulfonate-tetrandrine Derivatives As Potential Chemotherapeutic Agents for Hepatocellular Carcinoma

Synthesis and Biological Evaluation of Novel Anti-Hepatitis C Virus (HCV) Agents: 2-Hydroxylphenethyl Sulfanyl-Oxopyrimidines

Rational Synthesis and Preliminary Anti-cancer Activities of 18Β-Glycyrrhetinic Acid Derivatives Containing Pyridinecarboxamide

Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives

Design, Synthesis, and Antitumor Evaluation of Novel Mono-Carbonyl Curcumin Analogs in Hepatocellular Carcinoma Cell

Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.